Please check your internet connection and try again.
# Isoxsuprine Hydrochloride
## Overview
Isoxsuprine hydrochloride is a vasodilator that acts primarily on peripheral blood vessels. It is thought to exert its effects by relaxing vascular smooth muscle, leading to vasodilation and improved blood flow.
## Primary Indications
* Treatment of peripheral vascular disease, including intermittent claudication and vasospastic disorders.
* Improvement of cerebrovascular insufficiency.
* *Note: Clinical efficacy for these indications is debated and not universally accepted.*
## Adult Dosing
* **Typical dose:** 10 mg to 20 mg orally three to four times daily.
* **Maximum dose:** Not well-established, but doses exceeding 20 mg four times daily are not generally recommended due to lack of demonstrated additional benefit and increased risk of adverse effects.
## Pediatric Dosing
* No established pediatric dosing. Use in children is generally not recommended.
## Dose Adjustments
* **Renal impairment:** No specific guidelines, but caution may be warranted in severe renal impairment due to potential for accumulation.
* **Hepatic impairment:** No specific guidelines, but caution may be warranted in severe hepatic impairment.
## Contraindications
* Hypersensitivity to isoxsuprine hydrochloride.
* Use in the immediate post-partum period.
* Use in patients with congenital heart disease.
* Use in patients with hypotension.
## Adverse Effects
* **Common:** Nausea, vomiting, gastrointestinal distress, dizziness, headache, flushing, weakness, nervousness, rash.
* **Serious:** Hypotension, tachycardia, chest pain, blurred vision.
## Key Drug Interactions
* **Antihypertensives:** Isoxsuprine may potentiate the hypotensive effects of antihypertensive medications. Monitor blood pressure closely.
* **Other vasodilators:** Concurrent use may increase the risk of hypotension.
## Monitoring
* Blood pressure.
* Heart rate.
* Symptoms of peripheral vascular disease.
* Signs of adverse effects.
## Clinical Pearls
* Isoxsuprine's efficacy in treating peripheral vascular disease is controversial, and its use has declined.
* Administer with food to minimize gastrointestinal upset.
* Avoid abrupt discontinuation.
* Not recommended for patients with glaucoma.
***
*This information is intended for healthcare professionals and does not replace the need to consult current prescribing information, clinical guidelines, and institutional protocols before prescribing.*
